SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Reshmi Chatterjee, Abhisek Mitra, An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer, International Immunopharmacology, 2015, 24, 2, 335

    CrossRef

  2. 2
    Richard A Colvin, Tawesak Tanwandee, Teerha Piratvisuth, Satawat Thongsawat, Aric Josun Hui, Hongfei Zhang, Hong Ren, Pei-Jer Chen, Wan-Long Chuang, Abhasnee Sobhonslidsuk, Ruobing Li, Yin Qi, Jens Praestgaard, Yi Han, Junfang Xu, Daniel S Stein, Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection, Journal of Gastroenterology and Hepatology, 2015, 30, 1
  3. 3
    Mohamad S. Hakim, Michelle Spaan, Harry L. A. Janssen, Andre Boonstra, Inhibitory receptor molecules in chronic hepatitis B and C infections: novel targets for immunotherapy?, Reviews in Medical Virology, 2014, 24, 2
  4. 4
    Yuecheng Yu, Jinlin Hou, Masao Omata, Yue Wang, Lanjuan Li, Loss of HBsAg and antiviral treatment: from basics to clinical significance, Hepatology International, 2014, 8, 1, 39

    CrossRef

  5. 5
    Robert E. Lanford, Bernadette Guerra, Deborah Chavez, Luis Giavedoni, Vida L. Hodara, Kathleen M. Brasky, Abigail Fosdick, Christian R. Frey, Jim Zheng, Grushenka Wolfgang, Randall L. Halcomb, Daniel B. Tumas, GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees, Gastroenterology, 2013, 144, 7, 1508

    CrossRef

  6. 6
    Harald Farnik, Jörg Bojunga, Annemarie Berger, Regina Allwinn, Oliver Waidmann, Bernd Kronenberger, Oliver T. Keppler, Stefan Zeuzem, Christoph Sarrazin, Christian M. Lange, Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients, Hepatology, 2013, 58, 4
  7. 7
    Bengu Ekinci Koktekir, Sua Sumer, Berker Bakbak, Sansal Gedik, Saban Gonul, Onur Ural, Ocular effects of pegylated interferon-α in patients with chronic hepatitis B, Cutaneous and Ocular Toxicology, 2013, 32, 4, 275

    CrossRef

  8. 8
    Petros C. Benias, Albert D. Min, Goals of Antiviral Therapy for Hepatitis B: HBeAg Seroconversion, HBsAg Seroconversion, Histologic Improvement, and Possible Impact on Risk of Hepatocellular Carcinoma, Current Hepatitis Reports, 2011, 10, 4, 292

    CrossRef

  9. 9
    Michael Chang, Sammy Saab, Interferon for Hepatitis B: Which Populations Benefit the Most, Current Hepatitis Reports, 2011, 10, 4, 285

    CrossRef

  10. You have free access to this content10
    W. S. Ayoub, E. B. Keeffe, Review article: current antiviral therapy of chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2011, 34, 10